REVIEW 2 cited by
Quantum AI for Alzheimer's disease early screening
Not yet reviewed by Pith; the record is open.
This paper has not been read by Pith yet. Machine review is queued; the pith claim, tier, and objections will appear here once it completes.
SPECIMEN: schema-true, not a live event
T0 review · schema-true
One-sentence machine reading of the paper's core claim.
pith:XXXXXXXX · record.json · timestamp
read the original abstract
Quantum machine learning is a new research field combining quantum information science and machine learning. Quantum computing technologies appear to be particularly well-suited for addressing problems in the health sector efficiently. They have the potential to handle large datasets more effectively than classical models and offer greater transparency and interpretability for clinicians. Alzheimer's disease is a neurodegenerative brain disorder that mostly affects elderly people, causing important cognitive impairments. It is the most common cause of dementia and it has an effect on memory, thought, learning abilities and movement control. This type of disease has no cure, consequently an early diagnosis is fundamental for reducing its impact. The analysis of handwriting can be effective for diagnosing, as many researches have conjectured. The DARWIN (Diagnosis AlzheimeR WIth haNdwriting) dataset contains handwriting samples from people affected by Alzheimer's disease and a group of healthy people. Here we apply quantum AI to this use-case. In particular, we use this dataset to test classical methods for classification and compare their performances with the ones obtained via quantum machine learning methods. We find that quantum methods generally perform better than classical methods. Our results pave the way for future new quantum machine learning applications in early-screening diagnostics in the healthcare domain.
Forward citations
Cited by 2 Pith papers
-
Quantum Transfer Learning to Boost Dementia Detection
Applying quantum transfer learning to a weak CNN raises reported dementia detection accuracy on OASIS-2 from 73 percent to 91 percent, but the comparison lacks error bars and uses test-set-based model selection.
-
Parallelizing Drug Discovery: HPC Pipelines for Alzheimer's Molecular Docking and Simulation
On a small amyloid-beta system, GROMACS gains little from more than 2 OpenMP threads, while a Python multiprocessing docking loop reaches about 9x speedup at 500 conformers.
Discussion (0). Continue with ORCID to comment.